NA
Nezam H. Afdhal
Highly rated in
22
conditions

Dr. Nezam H. Afdhal

BIDMC - Division Of Gastroenterology/Liver Center
Boston, MA
Highly rated in
22
conditions
Specialties:Gastroenterology
Experience:42 Years
Age:67
Accepts:New PatientsMedicare
Highly rated in
22
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Nezam H. Afdhal's experience treating your condition:
About Dr. Nezam H. Afdhal

Nezam Afdhal is a Gastroenterologist in Boston, Massachusetts. Afdhal has been practicing medicine for over 42 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, and Liver Transplant. He is licensed to treat patients in Massachusetts. Afdhal is currently accepting new patients.

His clinical research consists of co-authoring 169 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nezam H. Afdhal it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Nezam H. Afdhal accepts the following insurance:

  •  Ambetter
  •  Anthem
Call to see if your plan is accepted.
Locations
110 Francis St, Suite 8e, Boston, MA 02215
Background & Education
Graduate Institution
Other, 1981
Specialties
Gastroenterology
Licenses
Internal Medicine in MA
Hospital Affiliations
Beth Israel Deaconess Hospital - Milton
Milford Regional Medical Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Hospital - Needham
Beth Israel Deaconess Hospital - Plymouth
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials
A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: July 17, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects
Enrollment Status: Completed
Publish Date: July 12, 2018
Intervention Type: Diagnostic Test
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Enrollment Status: Completed
Publish Date: October 27, 2017
Intervention Type: Device
Study Phase: Not Applicable
Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial
Enrollment Status: Completed
Publish Date: July 11, 2017
Intervention Type: Drug
Study Phase: Phase 4
Phase II, Randomized, Double-blind, Placebo-controlled Study of Nitazoxanide in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Hepatitis C
Enrollment Status: Completed
Publish Date: February 10, 2014
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Multicenter, Randomized, Double-masked, Placebo-controlled Phase II Study to Assess the Safety and Efficacy of a Standardized Orally Administered Silymarin Preparation (Legalon) for the Treatment of Patients With Chronic Hepatitis C Who Failed Conventional Antiviral Therapy
Enrollment Status: Completed
Publish Date: March 18, 2013
Intervention Type: Other, Drug
Study Phase: Phase 2
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
Enrollment Status: Completed
Publish Date: July 08, 2008
Intervention Type: Drug
Study Phase: Phase 3
Single and Multiple Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered Silymarin (Legalon) in Non-Cirrhotic Subjects With Chronic Hepatitis C or Non-Alcoholic Fatty Liver Disease
Enrollment Status: Completed
Publish Date: February 20, 2008
Intervention Type: Drug
Study Phase: Phase 1
Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon
Enrollment Status: Completed
Publish Date: September 11, 2006
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials -
169 Total Publications
A phase 2, open-label, randomized, multiple dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 30, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
JF
Joseph D. Feuerstein
Dr. Joseph D. Feuerstein
Gastroenterology
Highly rated in
35
conditions
Gastroenterology

Beth Israel Lahey Health

Division Of Infectious Disease

110 Francis St, 
Boston, MA 

Joseph D. Feuerstein, MD, is a Staff Physician in the Division of Gastroenterology, Beth Israel Deaconess Medical Center. He is also on staff at Boston Endoscopy Center.

MS
Dr. Mandeep S. Sawhney
Gastroenterology
Highly rated in
53
conditions
Gastroenterology

Beth Israel Lahey Health

Beth Isreal Deaconess Medical Center

330 Brookline Ave, 
Boston, MA 
 0.3 mi

Mandeep Sawhney is a Gastroenterologist in Boston, Massachusetts. Sawhney has been practicing medicine for over 31 years and is highly rated in 53 conditions, according to our data. His top areas of expertise are Choledocholithiasis, Barrett Esophagus, Pancreatic Cancer, Endoscopy, and Colonoscopy. He is licensed to treat patients in Massachusetts. Sawhney is currently accepting new patients.

HK
Hamed Khalili
Dr. Hamed Khalili
Gastroenterology
Highly rated in
21
conditions
Gastroenterology

Mass General Brigham

Gastroenterology Assoc/Digestive Health Center

165 Cambridge St, 
Boston, MA 
 2.8 mi

Hamed Khalili, MD, MPH is a Gastroenterologist and Internist specializing in Inflammatory Bowel Disease at Massachusetts General Hospital.